Krystal Biotech, Inc. Share Price

Krystal Biotech, Inc. Share Price

NASDAQ: KRYS | Mid Cap
$324.27
+$3.62 (1.13%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Krystal Biotech, Inc. Stock Performance

Open
$326.42
Prev. Close
$320.65
Circuit Range
N/A
Day Range
$319.69 - $326.42
Year Range
$183.47 - $382.01
Volume
14,626
Average Traded
$323.86

Krystal Biotech, Inc. Share Price Today

As of 30 October 2026, Krystal Biotech, Inc.'s share price is $324.27. The stock opened at $326.42, compared to its previous close of $320.65. During today's trading session, Krystal Biotech, Inc.'s share price traded between $319.69 and $326.42, with an average price of $323.06. Over the past 52 weeks, the stock has recorded a high of $382.01 and a low of $183.47. In terms of performance, Krystal Biotech, Inc.'s share price has risen by 23.57% over the last six months and is up 64.55% on a year-on-year basis.

Krystal Biotech, Inc. Share Price Chart

Line chart of the Krystal Biotech, Inc. price trend over the selected period. The price rose overall, ranging from 319.69 to 327.36, ending at 324.27.
$319.69$326.42
L
Show Current Price
H

Krystal Biotech, Inc. Stock Fundamentals & Key Indicators

Market Cap
$9.39B
PE Ratio (TTM)
39.40
Dividend Yield
0.00%
EPS (TTM)
$8.16
Revenue (TTM)
$389.13B
Return On Equity (TTM)
17.77%
Profit Margin
52.64%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-30.99%

Krystal Biotech, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$97.80$107.11$116.36$119.22
Net Profit$79.37$51.40$55.93$54.77
Net Profit Margin81.16%47.99%48.07%45.94%
Income ChangeN/A-35.24%8.81%-2.07%

Krystal Biotech, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$50.70$290.52$389.13
Net Profit-$139.98$10.93$89.16$204.83
Net Profit MarginN/A21.56%30.69%52.64%
Income ChangeN/A107.81%715.74%129.73%

About Krystal Biotech, Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Krystal Biotech, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$330.56
$324.39
-2.70%
Sep 2026
$360.80
$333.38
-6.74%
Aug 2026
$322.00
$357.49
+4.81%
Jul 2026
$369.77
$341.08
-8.25%
Jun 2026
$306.16
$371.74
+20.25%
May 2026
$263.03
$309.14
+17.80%
Apr 2026
$258.50
$262.42
+1.79%
Mar 2026
$267.50
$257.81
-6.37%
Feb 2026
$279.99
$275.35
-1.38%
Jan 2026
$245.06
$279.19
+12.87%
Dec 2025
$213.98
$247.35
+13.87%
Nov 2025
$196.15
$217.22
+10.23%

KRYS Share Price FAQs